Lotus Pharmaceutical Co Ltd (1795) — Cash Flow Quality Index
Lotus Pharmaceutical Co Ltd (1795) has a Cash Flow Quality Index of 1.03x as of December 2025. Operating cash flow of NT$1.35 Billion exceeds net income of NT$1.32 Billion, indicating high earnings quality where cash backs reported profits. Explore Lotus Pharmaceutical Co Ltd cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Lotus Pharmaceutical Co Ltd Cash Flow Quality Index (2009–2025)
Historical Cash Flow Quality Index for Lotus Pharmaceutical Co Ltd across 14 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Lotus Pharmaceutical Co Ltd (1795) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Lotus Pharmaceutical Co Ltd (2009–2025)
Year-by-year earnings quality comparison for Lotus Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see market cap of Lotus Pharmaceutical Co Ltd.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.31x | NT$7.48 Billion | NT$5.72 Billion | ▲ +35.2% |
| 2024 | 0.97x | NT$6.15 Billion | NT$6.36 Billion | ▲ +146.2% |
| 2023 | 0.39x | NT$1.61 Billion | NT$4.11 Billion | ▼ -58.3% |
| 2022 | 0.94x | NT$3.72 Billion | NT$3.94 Billion | ▲ +1375.2% |
| 2021 | 0.06x | NT$119.66 Million | NT$1.87 Billion | ▼ -95.7% |
| 2020 | 1.49x | NT$1.95 Billion | NT$1.30 Billion | ▲ +332.4% |
| 2019 | 0.35x | NT$302.81 Million | NT$876.42 Million | ▼ -92.9% |
| 2018 | 4.87x | NT$796.98 Million | NT$163.70 Million | ▲ +73.3% |
| 2017 | 2.81x | NT$592.29 Million | NT$210.81 Million | ▼ -95.6% |
| 2016 | 64.02x | NT$1.23 Billion | NT$19.26 Million | ▲ +1711.2% |
| 2015 | 3.53x | NT$1.08 Billion | NT$304.87 Million | ▲ +181.8% |
| 2013 | -4.32x | NT$-95.84 Million | NT$22.19 Million | ▼ -209.8% |
| 2010 | 3.93x | NT$59.19 Million | NT$15.05 Million | ▼ -86.3% |
| 2009 | 28.71x | NT$89.50 Million | NT$3.12 Million | — |